Clinical Trials Browser

Phase 2 × Semaxinib × Dermatologic × Clear all

NCT00017316 2013-02-11

Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Melanoma

NCT00006003 2013-01-24

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Phase 2 Terminated

Melanoma

NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Phase 2 Completed

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Phase 2 Completed

DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections